Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Mindfulness-Art Therapy Intervention in Abused Adolescents

25 juni 2026 bijgewerkt door: Asieh Hasanpour Souderjani, Ardakan University

Effectiveness of the Mindfulness and Art Therapy Group Program on Body Self-Concept and Shame in Adolescents With a History of Abuse

Adolescence is an important stage of development when many mental health difficulties first appear. Young people who have experienced abuse are especially vulnerable, as abuse can lead to intense feelings of shame and negatively affect their body self-concept. This study explored whether a group program combining mindfulness and art therapy-called the Mindfulness and Art Therapy Group Program (MATG-P)-could help adolescents with a history of abuse. Mindfulness helps young people become more aware of their thoughts and feelings in a nonjudgmental way, while art therapy allows them to express emotions safely and creatively. Although both approaches have been used separately, their combined effect was not previously studied among vulnerable adolescents. . Therefore, this study aimed to investigate the effectiveness of the Mindfulness and Art Therapy Group Program on body self-concept and shame in adolescents with a history of abuse.

After completing the intervention and analyzing the data, it was concluded that adolescents who participated in the program showed significant improvements in how they viewed their bodies and experienced lower levels of shame compared to those who did not receive the intervention. These findings suggest that combining mindfulness and art therapy in a group setting may be an effective way to support adolescents who have experienced abuse. Overall, this study highlights the potential contribution of MATG P as a supportive intervention to improve body self-concept and reduce shame among adolescents with a history of abuse.

Studie Overzicht

Studietype

Ingrijpend

Inschrijving (Werkelijk)

40

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

      • Isfahan, Iran
        • Children and Adolescent Care Center, Isfahan Welfare Organization

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Kind
  • Volwassen

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Having a history of abuse
  • sufficient physical and cognitive ability to participate in the intervention

Exclusion Criteria:

  • Having intellectual disability, developmental delay, visual or sensory motor impairments
  • a diagnosed psychiatric disorder recorded in the Child Welfare Organization's files

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Dubbele

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: MATG-P
The experimental group received 8 sessions of Mindfulness and Art Therapy Group Program (MATG-P), each lasting 45-60 minutes.
Each session of MATG-P included three components: a meditation practice of 10 to 15 minutes, a reflective art activity of 20 to 30 minutes, and a therapeutic discussion of about 15 minutes. Session's themes followed the original curriculum, beginning with body and breath awareness in the first three weeks. Emotional awareness was emphasized in weeks four and five, where pleasant, unpleasant, and neutral feelings were explored. Week six focused on awareness of awareness of attitudes, while weeks seven and eight were dedicated to values and loving kindness practices. Caregiver-child meetings were designed in the first and last weeks, during which adolescents guided their caregivers in meditation, thereby reinforcing mindfulness and art practices beyond the intervention sessions.
Geen tussenkomst: control group
Adolescents allocated to the control group did not receive any intervention during the study period. Adolescents in the control group were placed on a waiting list and, if still residing at the center, were offered the intervention after the study finished. They continued with their routine activities and the services provided by the Welfare Organization, but no structured therapeutic program was delivered to them. To minimize attention effect, the control group engaged in brief, non-therapeutic sessions designed to control for attention without incorporating the specific techniques of MATG P. These sessions consisted of neutral, informational discussions while avoiding any direct engagement in mindfulness-based techniques or art therapy. This design enabled a direct comparison between adolescents who received MATG P and the control g

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Body self-concept
Tijdsspanne: Baseline: 1 day before the first intervention session Post-test: 1 day after the final intervention session
Body self-concept is a central dimension of self-concept, which includes the thoughts, beliefs, emotions, and behaviors associated with the perceived body and is experienced more as a feeling rather than explicit verbal descriptions. It was measured using the Piers-Harris Children's Self-Concept Scale (PHCSCS). Scores range from 0 to 80. Higher scores indicate a more positive body self-concept.
Baseline: 1 day before the first intervention session Post-test: 1 day after the final intervention session
shame
Tijdsspanne: Baseline: 1 day before the first intervention session Post-test: 1 day after the final intervention session
Shame is a self-conscious emotion characterized by negative evaluations of the self, feelings of worthlessness, inferiority, and self-devaluation. It was measured using the Guilt and Shame Experience Scale (GSES). Scores range from 8 to 32, with higher scores indicating greater experiences of shame.
Baseline: 1 day before the first intervention session Post-test: 1 day after the final intervention session

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

26 februari 2025

Primaire voltooiing (Werkelijk)

29 september 2025

Studie voltooiing (Werkelijk)

29 september 2025

Studieregistratiedata

Eerst ingediend

20 juni 2026

Eerst ingediend dat voldeed aan de QC-criteria

25 juni 2026

Eerst geplaatst (Werkelijk)

29 juni 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

29 juni 2026

Laatste update ingediend die voldeed aan QC-criteria

25 juni 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren